Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation
about
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPVEarly direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewUrban and rural safety net health care system clinics: no disparity in HPV4 vaccine completion rates.Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trialIntroduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV typesImmunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.Human papillomavirus vaccination: the population impact.Human papilloma virus vaccination: impact and recommendations across the world.Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes.Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine.Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study.The epidemiology of sexually transmitted infections in the UK: impact of behavior, services and interventions.Prophylactic HPV vaccination: past, present, and future.Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.Cervical cancer: A comprehensive approach towards extermination.Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials.Impact of genital warts on emotional and sexual well-being differs by gender.Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.Current status and future prospects for human papillomavirus vaccines.Cost-effectiveness of human papillomavirus vaccination in Germany.Impact of HPV vaccination: health gains in the Italian female population.Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination.Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection.Comparative Cost-Effectiveness Analysis of Two Different Two-Dose Human Papillomavirus Vaccines in MalaysiaHPV prophylactic vaccines: lessons learned from 10 years experienceThe epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems
P2860
Q26783973-48FAAA83-98DC-4013-8D75-8B088EB796B7Q28081927-9142860E-20C6-4E2E-9620-9F885E6533AFQ31160912-DD3A2338-80DE-490F-993E-8227E289D261Q33626255-A128C0EB-12B5-45C0-A1AC-88C8C080852BQ33682928-1943D0AA-FB5F-4CBD-B934-623D81DB86D0Q33723312-A29957A3-08A0-4614-9B9E-8025C673C5E2Q33806566-DA8D8D69-C2F6-45A2-BACB-260DAC4C639AQ34704575-04A7EBAF-1210-4CE3-812C-E225A856FCEBQ35095954-3B9C0EB7-9DA6-45C2-8F0F-6DAD4A82F181Q35221177-9F7BF43A-AF12-4BFE-927B-E89F3A2CDACBQ35887542-BBEB1D0F-3A7E-452E-BDBE-0BB865F66705Q37213048-96FCC0AB-C5F3-483D-AA0F-3F93BDF74653Q38322744-43117B17-8CD5-43DF-A713-3053E9D8B047Q38597567-5E4BBE70-989A-4FD5-AF52-B16D940198F7Q38673879-79FD4061-79C8-4E08-8AF8-EC754D1BACE8Q38748682-28664D58-1F81-42EA-95CD-9C79B51A2AFEQ38993490-6883EDD1-71D1-429F-B3D5-53B781857D3FQ39565796-DA7B8C5F-A5AE-4891-877F-F8B356FA587EQ39640508-E9218C92-280F-4A4E-96D7-E3084152C454Q40056541-C22335D7-F824-435E-83EE-BAAB5FF02495Q40063569-60A07052-B066-4455-9B86-7E3433ABEF09Q42368107-C992758A-3BD3-42E5-A9B4-257C8B4A4431Q44058920-657035A0-9B26-4B84-B1EB-6502486A9A31Q49664919-1109714B-C284-4552-AB2E-CD1816A56E10Q55540751-74450DFD-5AD4-460A-AD07-4156B7F3F68BQ56067928-41D775F8-EE5D-4957-AA68-722B774EA0FEQ58049672-89A4ACF7-8F7D-43A2-B656-886B1C392037
P2860
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Efficacy of the HPV-16/18 AS04 ...... al): an unexpected observation
@en
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types
@nl
type
label
Efficacy of the HPV-16/18 AS04 ...... al): an unexpected observation
@en
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types
@nl
prefLabel
Efficacy of the HPV-16/18 AS04 ...... al): an unexpected observation
@en
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types
@nl
P2093
P2860
P50
P356
P1476
Efficacy of the HPV-16/18 AS04 ...... al): an unexpected observation
@en
P2093
Anne Szarewski
Archana Chatterjee
Aureli Torné
Barbara Romanowski
Diane M Harper
Gary Dubin
Jose Bajo-Arenas
Julio C Teixeira
M Rowena Del Rosario-Raymundo
Maria Castro-Sanchez
P2860
P304
P356
10.1093/INFDIS/JIT360
P407
P577
2013-11-01T00:00:00Z